Concepedia
8
Publications
1.4K
Citations
H-Index
2011
Active since
Affiliations
Clinica Universidad de Navarra(Current)
Centro de Investigación Biomédica en Red de Cáncer
Universidad de Salamanca
Instituto de Investigación Biomédica de Salamanca
Centro de Investigación del Cáncer
Sara Rodríguez is an author at Clinica Universidad de Navarra.
Publications per year
2011–2023
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
Ranjana H. Advani, Joseph J. Buggy, Jeff P. Sharman et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Ibai Goicoechea, Noemí Puig, María‐Teresa Cedena et al. · Blood · 2020 · 127 citations · Full text
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Rosalinda Termini, David Žihala, Evangelos Terpos et al. · Clinical Cancer Research · 2022 · 46 citations · Full text
The Bruton's Tyrosine Kinase Inhibitor PCI-32765 Is Highly Active As Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary Results of a Phase II Trial
Lühua Wang, Peter Martin, Kristie A. Blum et al. · Blood · 2011 · 41 citations
Preneoplastic somatic mutations including <i>MYD88</i> <sup>L265P</sup> in lymphoplasmacytic lymphoma
Sara Rodríguez, Jon Celay, Ibai Goicoechea et al. · Science Advances · 2022 · 39 citations · Full text
Rows per page
1–5 of 8